Table 1. Characteristics of studies included in the meta-analysis.
| Author | Year | Country | Sample size* | Age, Mean (SD) | Duration of ADT | Supervision | ||
|---|---|---|---|---|---|---|---|---|
| IT | C | IT | C | |||||
| Alberga et al. [17] | 2012 | Canada | 23 | 26 | 66.0 (—) | 66.0 (—) | —— | Supervised |
| Cormie et al. [24] | 2015 | Australia | 32 | 31 | 69.6 (6.5) | 67.1 (7.5) | Just started | Supervised |
| Galvão et al. [18] | 2010 | Australia | 29 | 28 | 69.5 (7.3) | 70.1 (7.3) | ≥2 months | Supervised |
| Kim et al. [35] | 2018 | Korea | 26 | 25 | 70.5 (5.0) | 71.0 (5.5) | Mean: 22 months | Home-based |
| Lam et al. [36] | 2020 | Australia | 13 | 12 | 69.3 (2.3) | 71.8 (1.8) | Just started | Home-based |
| Ndjavera et al. [37] | 2020 | UK | 24 | 26 | 71.4 (5.4) | 72.5 (4.2) | Just started | Supervised |
| Newton et al. [21] | 2019 | Australia | 57 | 47 | 68.7 (9.3) | 69.1 (8.4) | >2 months | Supervised |
| Nilsen et al. [38] | 2015 | Norway | 28 | 30 | 66.0 (6.6) | 66.0 (5.0) | ≥6 months | Supervised |
| Taaffe et al. [22] | 2018 | Australia | 28 | 29 | 73.0 (5.2) | 72.2 (8.4) | ≥2 months | Supervised |
| Taaffe et al. [23] | 2019 | Australia | 54 | 50 | 69.0 (6.3) | 67.5 (7.7) | Just started | Supervised |
| Villumsen et al. [39] | 2019 | Danish | 23 | 23 | 67.6 (4.9) | 69.8 (4.4) | ≥9 months | Home-based |
| Winters-Stone et al. [25,40] | 2014/2015 | America | 29 | 22 | 69.9 (9.3) | 70.5 (7.8) | Mean: 30 months | Supervised |
*Sample size includes lost to follow-up.